Pfizer will produce its COVID-19 vaccine from its Grange Castle facility in Dublin, as part of a $40 million investment. The firm’s partnership with BioNTech saw Pfizer become the first company to bring a messenger RNA-based product to market, namely the COVID-19 vaccine Comirnaty (BNT162b2). Pfizer’s CEO Albert Bourla told shareholders at its annual meeting in April that it is comfortable the firm will produce 3 billion doses of the vaccine in 2021 and will further invest in its manufacturing…
Thursday, May 20, 2021 Daily Archives
Canada pays $164 million to add Resilience to pandemic prep effort
Canada has called on Resilience Biotechnologies to boost local COVID-19 shot capacity. The Canadian Government has given contract development manufacturing organization (CDMO) Resilience Biotechnologies $164 million to modernize its recently acquired Ontario plant as part of a wider pandemic preparedness effort. The CDMO – which is part of San Diego, US based headquartered firm National Resilience – announced further details this week. It said the investment will increase manufacturing capacity for vaccines and therapeutics, including those based on mRNA that…